A Phase II Study of Adjuvant Chemotherapy of S-1 With Oxaliplatin in Gastric Cancer at Stage IIIB/ IV (AJCC 6th) After D2 Resection
Phase of Trial: Phase II
Latest Information Update: 20 Mar 2018
Price : $35 *
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Oxaliplatin
- Indications Adenocarcinoma; Gastric cancer
- Focus Therapeutic Use
- Acronyms SOHUG
- 14 Mar 2018 Planned End Date changed from 1 Feb 2019 to 1 Feb 2020.
- 14 Mar 2018 Planned primary completion date changed from 1 Feb 2019 to 1 Feb 2020.
- 26 Apr 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.